Maccura Biotechnology Co., Ltd.
迈克生物
300463
Shenzhen Stock Exchange
Company Profile
1. Technology and R&D Advantages The company has the world-leading R&D team. Led by the chief scientists, R&D Center has established several technology development platforms which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, molecular diagnosis and biomass etc. The company has been enriching and optimizing the product line through continuous research and development investment. 2. Advantages of the System of Production and Quality Management The company possesses world-class production conditions and production management level. The products cover 90% needs of medical laboratories. Maccura become the first enterprise member at IFCC and is the first batch of IVD enterprises in China to build reference laboratories for measurement traceability work. 3. Advantages of Product and Marketing Services The company has abundant market management experience and channel management ability, professional sales service capability and product resource integration advantages, which can provide perfect professional services, including the comprehensive design and management of laboratory, actuary of the purchasing of configurations, the optimization of the processes etc. for the product dealers and end customers. The company promotes the marketing network construction actively. At present, there are 13 wholly owned and controlling subsidiaries, 25 offices, and the business covers all regions of China except HK, Macao and Taiwan.
Full description
Founded in 1994, Maccura Biotechnology Co., Ltd. has been focusing on the R&D, manufacture, sales of IVD products and relevant services. We are certified by national departments as High-Tech Enterprises, and has passed CMD ISO13485, CQC ISO14001, TUV ISO13485 certification and products CE certification. Up to now, maccura has the first-class R&D, manufacture, management and operation team in the world. Also, it has accomplished the development pattern of the entire industrial chain, ranging from biological raw materials and products from medical laboratories to professional services. It is systematically and professionally capable of the R&D and manufacture of IVDs, reagents, calibration products and quality-control products, which cover the technology platforms of clinical chemistry, immunoassay, POCT, hematology, coagulation, molecular diagnosis and pathology, which accomplishes more than 90% demands of clinical labs. Maccura is the first corporate member from China of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) to fill the gaps in this field of China; maccura is the first manufacturer of China won CNAS medical reference laboratory accreditation; maccura is the only manufacturer elected into JCTLM medical reference measurement laboratory list; and maccura is the cooperate member of The Institute for Reference Materials and Measurements (IRMM) to value assignment of international reference materials and reference methods. ? We are closely integrated with well-known domestic and foreign R&D institutions and formed a distinctive innovation system through the most advanced R&D team, production and testing equipment in the world. We have cooperated with relevant social units, laboratories and individuals to build a 21st Century Innovative Laboratory for Laboratory Medicine. We have a wealth of market management experience and channel management capabilities for product distributors and end customers to provide professional services. While realizing the breakthroughs in scientific research and production value with scientific concepts of “innovation”, “precision”, etc., maccura adheres to the mission of “Science & Technology Serve Human Health”, persists on the promotion of ability of value traceability and the establishment of medical laboratories, and regards providing quality products to clients as the honor and duty, and the human life health as the continuous power and direction. We regard "To be a World-Class IVD enterprise” as the corporate vision to provide quality products and services worldwide through continuous technological innovation.